Certara to acquire chemaxon to strengthen drug discovery software portfolio

Combined organization brings broader predictive capabilities to drug discovery at scale reiterates full year 2024 guidance radnor, pa., july 09, 2024 (globe newswire) -- certara, inc. (nasdaq: cert), a global leader in model-informed drug development, today announced it has signed a definitive agreement to acquire chemaxon, a leading provider of cheminformatics software.
CERT Ratings Summary
CERT Quant Ranking